Hélène Robitaille is elected to the IRCM's Board of Directors
MONTREAL, Feb. 22, 2012 /CNW Telbec/ - Yesterday, at a corporation assembly for the Institut de recherches cliniques de Montréal (IRCM), Hélène Robitaille was elected as a member of the Board of Directors.
"We are very proud to welcome Mrs. Robitaille to our Board of Directors," said Louise Lambert-Lagacé, current Chair of the Board. "With her impressive and diversified background, she will bring an entirely new set of skills and expertise, which the IRCM will undoubtedly benefit from."
Hélène Robitaille is a civil engineer. She has worked in various fields, including administration and project management in the construction and telecommunications sectors, as well as in design and television production.
"I am delighted to join the IRCM's Board," added Mrs. Robitaille. "With the passion I have for science, I have always wanted to get involved in the field of biomedical research, particularly in an internationally-renowned institution."
About the IRCM
Founded in 1967, the IRCM (www.ircm.qc.ca) is currently comprised of 36 research units in various fields, namely immunity and viral infections, cardiovascular and metabolic diseases, cancer, neurobiology and development, systems biology and medicinal chemistry. It also houses three specialized research clinics, seven core facilities and three research platforms with state-of-the-art equipment. The IRCM employs 425 people and is an independent institution affiliated with the Université de Montréal. The IRCM clinic is associated to the Centre hospitalier de l'Université de Montréal (CHUM). The IRCM also maintains a long-standing association with McGill University.